HUMAW vs STE
Humacyte Inc (HUMAW) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
Humacyte Inc (HUMAW) common stock listed on NASDAQ.
STERIS plc (STE) is a medical devices company listed on NYSE.
HUMAW does not have a complete income-statement cache yet.
Latest reported STE revenue for 2026-03-31 was $5.94B. Net income was $782.3M. Revenue was up 8.7% from 2025-03-31 to 2026-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
HUMAW currently screens at market cap $0. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the HUMAW and STE stock pages for the full models.
Not investment advice.